Global Sexually Transmitted Disease (STD) Self-Testing Market Forecast to Reach $2.21 Billion by 2029, Driven by 9.8% CAGR
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Outlook for the Sexually Transmitted Disease (STD) Self-Testing Market Heading Into 2029?
The market size for self-testing of sexually transmitted diseases (STD) has seen substantial growth over the past few years. The market, valued at $1.38 billion in 2024, is projected to increase to $1.52 billion in 2025, with a compound annual growth rate (CAGR) of 10.1%. The key factors driving this growth during the historical period include enhanced awareness in relation to sexual health, the growing preference for home-based healthcare solutions, governmental initiatives promoting STD screening, increased accessibility to self-test kits sold over the counter, and escalating concerns regarding privacy during clinic-based tests.
In the next several years, robust growth is predicted within the market of self-testing for sexually transmitted diseases (STDs), with an anticipated value of $2.21 billion by 2029, signifying a compound annual growth rate (CAGR) of 9.8%. This expansion in the coming times is linked with the rising cases of sexually transmitted infections, the amplified call for user-friendly and confidential testing methods and the increase in the implementation of digital health elements in self-testing kits. Other contributing factors include the larger availability of at-home diagnostic tools in developing markets and the escalating affirmation of innovative self-testing technologies by sanctioning bodies. Some significant trends in this period will be progress in swift molecular diagnostic technologies, breakthroughs in mobile app assimilation for monitoring results, the composition of multi-infection self-testing kits, enhancements in covert packaging and delivery systems, and advancements in AI-assisted analysis of testing outcomes.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25901&type=smp
Which Factors Are Pushing The Sexually Transmitted Disease (STD) Self-Testing Market Forward?
The sexually transmitted disease (STD) self-testing market’s growth is poised to be spurred on by the escalating occurrence of syphilis. Seen as a sexually contracted infection, syphilis leads to body sores and could cause severe health issues if left untreated. There has been a significant increase in syphilis due to inconsistent usage of condoms, especially among groups participating in high-risk sexual activities. STD self-testing offers private and easily accessible syphilis testing at home, which encourages earlier diagnosis. This timely discovery allows immediate treatment, reduces complications, and halts further spread. For instance, the Centers for Disease Control and Prevention, an American government organization, noted approximately 209,253 reported cases of syphilis in 2023 — a 1% rise from 207,269 cases in the previous year. Therefore, the upsurge in syphilis cases fuels the expansion of the sexually transmitted disease (STD) self-testing market.
Which Segment Held The Largest Share In The Sexually Transmitted Disease (STD) Self-Testing Market In 2025?
The sexually transmitted disease (std) self-testing market covered in this report is segmented –
1) By Sample Type: Blood Based Test, Urine Based Test, Oral Based Test
2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
3) By Application: Chlamydia trachomatis (CT) Or Neisseria gonorrhoeae (NG) Testing, Syphilis Testing, Human Immunodeficiency Virus (HIV) Testing, Other Applications
Subsegments:
1) By Blood-Based Test: Fingerstick Blood Sample, Dried Blood Spot (DBS) Sample, Capillary Blood Collection Device
2) By Urine-Based Test: First-Catch Urine Sample, Midstream Urine Sample, Preservative-Added Urine Collection
3) By Oral-Based Test: Oral Swab Sample, Oral Fluid Collection Device, Gumline Swab Collection
How Are Key Trends Driving Expansion In The Sexually Transmitted Disease (STD) Self-Testing Industry?
Leading businesses in the STD self-testing market are channeling their efforts into crafting sophisticated products like over-the-counter (OTC) sample collection kits. These kits facilitate early discovery and immediate intervention for infections. They serve as domestically used diagnostic instruments that allow individuals to gather samples such as urine or swabs without requiring prescriptions, offering an accessible, private means of early infection recognition and swift treatment. In August 2023, for example, iHealth Labs Inc., an American digital health organization, brought to market the CheckMeSafe home collection kit for HIV and syphilis tests. Stamped with FDA approval, the kit is designed for anyone 18 or above to self-administer blood sample collection for HIV (I, II, P24 antigen) and syphilis tests from the safety and discretion of their own living spaces. The samples can be returned to the lab with a prepaid overnight label, and the confidential, trustworthy results can be expected in as few as two days. The kit impresses with its precision, offering detection rates up to 99.9% for HIV and 99.5% for syphilis. All samples undergo analysis in a laboratory certified by CLIA and accredited by CAP, ensuring that federal and state rigorous quality standards are met through frequent inspections.
Which Organizations Are Driving Progress In The Sexually Transmitted Disease (STD) Self-Testing Industry?
Major companies operating in the sexually transmitted disease (std) self-testing market are Abbott Laboratories, Viatris Inc., Hologic Inc., OraSure Technologies Inc., LifeCell International, LetsGetChecked Health Inc., Visby Medical Inc., Everlywell Inc., Guangzhou Wondfo Biotech Co. Ltd., NOWDiagnostics Inc., bioLytical Laboratories Inc., Atomo Diagnostics Limited, myLAB Box Inc., BioSure UK Ltd., JAL Medical (S) Pte Ltd., TBD Health Inc., Recombigen Laboratories Private Limited, Alpine Biomedicals Pvt. Ltd., Homed-IQ B.V., Newfoundland Diagnostics Pvt. Ltd.
Get The Full Report Here:
Which Region Is Expected To Experience The Highest Growth In The Sexually Transmitted Disease (STD) Self-Testing Industry?
North America was the largest region in the sexually transmitted disease (STD) self-testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted disease (std) self-testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=25901&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
